Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 2/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 8/20 | 0.39 |
| ▸ | ACLY | P53396 | 2/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.38 |
| ▸ | CES1 | P23141 | 5/20 | 0.37 |
| ▸ | CES2 | O00748 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL20527475 | 1.00 | FFAR3 (0.62) | FFAR3CYP2D6TSHRCYP2C19HIF1A | |
| Succinic Acid SCHEMBL27603519 | 0.87 | FFAR3 (0.48) | FFAR3TSHRFAAHHDAC3HDAC1 | |
| Trifluoroacetic Acid SCHEMBL9785203 | 0.87 | FFAR3 (0.62) | FFAR3TSHRFAAHHDAC3HDAC1 | |
| Trifluoroacetic Acid SCHEMBL31031817 | 0.87 | FAAH (0.42) | FFAR3CYP2D6TSHRCYP2C19HIF1A | |
| Trifluoroacetic Acid SCHEMBL27841664 | 0.87 | FAAH (0.42) | FFAR3CYP2D6TSHRCYP2C19HIF1A | |
| Trifluoroacetic Acid SCHEMBL29603858 | 0.85 | ALDH1A1 (0.59) | FFAR3FAAHCES1CES2MEN1 | |
| Trifluoroacetic Acid SCHEMBL27943966 | 0.85 | FFAR3 (0.42) | FFAR3TSHRFAAHCES1CES2 | |
| Trifluoroacetic Acid SCHEMBL27632684 | 0.85 | TDP1 (0.59) | FFAR3TSHRFAAHCES1CES2 | |
| Trifluoroacetic Acid SCHEMBL3794549 | 0.84 | FAAH (0.40) | FFAR3CYP2D6TSHRCYP2C19HIF1A | |
| Trifluoroacetic Acid SCHEMBL30324569 | 0.84 | FAAH (0.40) | FFAR3CYP2D6TSHRCYP2C19HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104387372-B | Oxo azetidine derivatives, preparation method and its purposes in human medical and cosmetics | 盖尔德马研究及发展公司 | 2018-06-26 | — | — | CN | claimed |
| CN-106795122-A | Nitric oxide donor carnosine compounds | 尼科斯科学爱尔兰公司 | 2017-05-31 | — | — | CN | claimed |
| US-7605267-B2 | Process for the preparation of 5-(halocetyl)-8-(substituted oxy)-(1h)-quinolin-2-ones | NOVARTIS AG (CH) | 2009-10-20 | — | — | US | claimed |
| CN-1054842-C | Platelet aggregation inhibitors | SEARLE & CO (US) | 2000-07-26 | — | — | CN | claimed |
| CN-1218460-A | Substituted 4-hydroxy-phenylalcanoic acid derivatives with activity to ppar-'gamma' | GLAXO GROUP LTD (GB) | 1999-06-02 | — | — | CN | claimed |
| CN-1124957-A | 1-amidinophenyl-pyrrolidones piperidinones azetinones as platelet aggregation inhibitors | SEARLE & CO (US) | 1996-06-19 | — | — | CN | claimed |
| WO-2026087635-A1 | DIHYDRO BENZOXAZINE DERIVATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2026-04-30 | — | — | WO | disclosed |
| CN-113226375-B | Methods and compositions | 英国研究与创新署 | 2025-05-13 | — | — | CN | disclosed |
| CN-119677757-A | Small molecules for boron neutron capture therapy | 艾维克放射性药物有限责任公司 | 2025-03-21 | — | — | CN | disclosed |
| US-20250090699-A1 | FAP TARGETING CYCLIC PEPTIDES AND CONJUGATES THEREOF | NOVARTIS AG (CH) | 2025-03-20 | — | — | US | disclosed |
| CN-119019309-A | GPR40 agonism-SSTR 5 antagonistic double-effect compound, preparation method and application thereof | 南昌大学 | 2024-11-26 | — | — | CN | disclosed |
| EP-4377318-A1 | PYRROLO [2, 3-B] PYRAZINE-BASED BIFUNCTIONAL COMPOUNDS AS HPK1 DEGRADERS AND THE USE THEREOF | BeiGene, Ltd. (KY) | 2024-06-05 | — | — | EP | disclosed |
| CN-118043324-A | Pyrrolo [2,3-b ] pyrazine-based bifunctional compounds as HPK1 degradants and uses thereof | 百济神州有限公司 | 2024-05-14 | — | — | CN | disclosed |
| WO-1993024475-A1 | SULPHAMIDE DERIVATIVES AS METALLOPROTEINASE INHIBITORS | CELLTECH LIMITED (GB) | 1993-12-09 | — | — | WO | disclosed |
| WO-1993014096-A1 | PHOSPHONO DERIVATIVES OF AMINO ACIDS AS METALLOPROTEINASE INHIBITORS | CELLTECH LIMITED (GB) | 1993-07-22 | — | — | WO | disclosed |
| CN-1063110-A | The amides derivative of the antibiotic GE2270 factor | GRUPPOLEPETIT S P A (IT) | 1992-07-29 | — | — | CN | disclosed |
| WO-1992009564-A1 | PEPTIDYL DERIVATIVES | CELLTECH LIMITED (GB) | 1992-06-11 | — | — | WO | disclosed |
| WO-1992009565-A1 | PEPTIDYL DERIVATIVES | CELLTECH LIMITED (GB) | 1992-06-11 | — | — | WO | disclosed |
| EP-0489577-A1 | Peptidyl derivatives | CELLTECH LIMITED (GB) | 1992-06-10 | — | — | EP | disclosed |
| EP-0489579-A1 | Peptidyl derivatives | CELLTECH THERAPEUTICS LIMITED (GB) | 1992-06-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250090699-A1 | FAP TARGETING CYCLIC PEPTIDES AND CONJUGATES THEREOF | FAP, FIBP, FGF23 | FFAR3 481/4885CYP2D6 4713/4885TSHR 1413/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.